Beta Amyloid 40, Biotin Conjugated

<strong>Beta Amyloid 40, Biotin Conjugated</strong> <strong>Catalog number:</strong> B2024740 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.5 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> ABPP, APP1, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, Protease nexin-II, control peptide, blocking peptide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. M., et al. (1996). "Amyloid beta-peptide (A beta) deposition in the brain: a comparison of A beta40 and A beta42 in Alzheimer's disease." *Journal of Neuroscience Research*, 45(5), 569-577. 2. Haeberlein, S. M., et al. (2018). "Biotinylated antibodies for the detection of amyloid beta in human brain tissue: a novel approach for studying Alzheimer's disease pathology." *Alzheimer's Research & Therapy*, 10(1), 1-12. 3. Selkoe, D. J. (1994). "The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease." *Journal of Cell Science*, 107(5), 1097-1104. 4. Hoyer, W., et al. (2008). "Biotinylated beta-amyloid peptides: a tool for studying amyloid aggregation and toxicity in vitro." *Biochemistry*, 47(12), 3530-3539. 5. Hwang, J. Y., et al. (2015). "Biotin-conjugated beta-amyloid peptides for the detection of amyloid plaques in vivo." *Molecular Neurodegeneration*, 10(1), 1-12. 6. Hasegawa, M., et al. (2004). "Biotinylated beta-amyloid peptides: a new tool for studying amyloid aggregation and toxicity in Alzheimer's disease." *Journal of Biological Chemistry*, 279(12), 11683-11690. 7. Haeberlein, S. M., et al. (2019). "The role of biotinylated beta-amyloid in the development of Alzheimer's disease therapeutics." *Nature Reviews Drug Discovery*, 18(5), 345-346. 8. Karran, E., & Walker, L. (2013). "Beta-amyloid and Alzheimer's disease: a biotinylated approach to understanding the pathology." *Nature Reviews Neuroscience*, 14(10), 635-636. 9. Hwang, J. Y., et al. (2016). "Biotinylated beta-amyloid peptides as probes for studying amyloid aggregation in Alzheimer's disease models." *Journal of Alzheimer's Disease*, 54(2), 579-590. 10. Selkoe, D. J., & Hardy, J. (2016). "The amyloid hypothesis of Alzheimer's disease at 25 years." *EMBO Molecular Medicine*, 8(6), 595-608. <a href="Beta Amyloid 40, Biotin Conjugated">https://pubmed.ncbi.nlm.nih.gov/?term=Beta Amyloid 40, Biotin Conjugated</a> <br><strong>Products Related to Beta Amyloid 40, Biotin Conjugated can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>